PeriVision
PeriVision is a Swiss medtech startup that builds the FDA- and CE-cleared VisionOne™ platform, combining VR headsets, cloud computing, and AI for visual field testing in glaucoma diagnosis, serving eye clinics, hospitals, and clinical trial sponsors.
- Company typePrivate
- Founded2021
- HeadquartersEpalinges, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What PeriVision does
PeriVision is a Swiss medtech startup that builds the VisionOne™ platform, a medical device combining virtual reality headsets, cloud computing, and artificial intelligence for visual field testing in glaucoma diagnosis and monitoring. The company originated as a University of Bern spinoff and operates from Epalinges, Switzerland, with a US subsidiary in Cambridge, Massachusetts. VisionOne allows ophthalmologists to configure eye examinations on portable VR headsets and analyze structured test results on a cloud backend, where AI algorithms optimize test administration, perform quality control, flag anomalies, and generate clinical decision insights; the platform claims test times under two minutes with maintained clinical accuracy. The system holds FDA 21 CFR Part 11 clearance and CE marking under EU MDR, positioning it for commercial sale in US and European ophthalmology markets.
PeriVision sells its platform via a direct enterprise sales motion targeting eye clinics, ophthalmology practices, hospital systems, and pharmaceutical clinical trial sponsors, with quote-based pricing and multi-year contracts rather than disclosed list prices. Distribution is regional, currently covering Switzerland and North America through the US subsidiary, with go-to-market support from industry conference participation (Swiss Ophthalmological Congress, Roche Creasphere) and earned media in trade publications. Customer segments split between primary ophthalmology end-users and a secondary clinical trial sponsor segment interested in at-home vision testing endpoints. The revenue model combines hardware sales (VR headsets) with what appears to be recurring cloud software / SaaS licensing for AI-powered analysis and decision support.
The company is in an early commercial stage: VisionOne launched in 2024 following a 2023 seed round and additional non-dilutive funding from EIT Health Wild Card, FIT, and Innosuisse, and a ~$3 million growth round led by Arya Ventures closed in September 2025. Headcount is reported at 1–10 employees, revenue is not publicly disclosed, and the company has been recognized through the 2025 Startup Nights Healthtech Award and selection for Innosuisse Scale-up Coaching. Leadership includes academic co-founders from the University of Bern (CEO Patrick Kessel, CTO Dr. Serife Kucur, board member Prof. Raphael Sznitman) alongside a Chief Medical Officer and Chief Commercial Officer.
PeriVision firmographics
Firmographics- Name
- PeriVision
- Legal name
- PeriVision SA
- Website
- https://perivision.io
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PeriVision is a Swiss medtech startup that builds the FDA- and CE-cleared VisionOne™ platform, combining VR headsets, cloud computing, and AI for visual field testing in glaucoma diagnosis, serving eye clinics, hospitals, and clinical trial sponsors.
- Ownership category
- akta.pro rank
PeriVision industry classification
Industry- Product category
- Ophthalmic Diagnostic Devices
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)
- akta.pro secondary industries
- Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty) (HLAHAJAI), Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
Keywords
Where PeriVision is headquartered
LocationHeadquarters
- HQ city
- Epalinges
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
PeriVision business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- VisionOne™ VR Platform: Sale of VR visual field diagnostic platform including hardware headsets and cloud-based software for eye testing and glaucoma monitoring. The platform appears to be sold as a complete system to eye clinics and healthcare providers.
- Cloud Software/SaaS: Cloud platform subscription or license for AI-powered analysis, quality control, and clinical decision support. Eye doctors configure tests and analyze results on the cloud platform, suggesting ongoing software licensing or subscription revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise diagnostic platform pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
PeriVision product offering
Product offeringCore offering
PeriVision develops and sells VisionOne™, a VR-based visual field diagnostic platform for eye clinics, hospitals, and clinical trial sponsors. The platform combines portable VR headsets, cloud-based test configuration and analysis software, and AI algorithms to perform fast (under 2 minutes) visual field assessments for glaucoma diagnosis and monitoring, including FDA-cleared and CE-cleared capabilities and remote/at-home testing for clinical trials.
Product overview
PeriVision offers a single unified product called the VisionOne™ platform. VisionOne is a VR-based visual field testing system designed specifically for glaucoma diagnosis and monitoring. The platform consists of portable VR headsets for test configuration and a cloud platform for results analysis. AI algorithms embedded in the backend optimize tests, automate assistance, control quality, and provide clinical decision insights.
Differentiator
Problem solved
Functional benefit
Brands
- VisionOne™: VR visual field platform for diagnosing and monitoring glaucoma with industry-leading speed and accuracy.
Products and services
- VisionOne™ VR Visual Field Platform VisionOne™ is a VR-based visual field diagnostic platform consisting of portable VR headsets and a cloud-based analysis platform, designed for eye doctors and ophthalmologists to diagnose and monitor glaucoma. The system delivers visual field assessments in under two minutes while maintaining clinical accuracy, with AI algorithms automating test assistance, optimizing tests, controlling quality, detecting anomalies, and providing clinical decision insights. It is FDA-cleared under 21 CFR Part 11 and CE-cleared under EU MDR, and supports at-home/remote vision testing for clinical trial endpoints.
Quantifiable outcome
- Test times reduced to under 2 minutes while maintaining clinical accuracy
- +1 more outcomes
Companies that use PeriVision
Customer profileSegments3 records
Ideal customer profiles3 records
PeriVision technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature4 records
PeriVision partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- University of BerncorePeriVision originated as a startup from the University of Bern, with co-founders Prof. Raphael Sznitman (board member) and Dr. Serife Kucur (CTO) affiliated with the university. The company develops solutions in collaboration with leading clinics, eye doctors, technicians, and patients.
- Roche CreasphereminorPeriVision presented at the Roche Creasphere EXPO Day in Basel, showcasing how at-home vision testing will revolutionize clinical trials. This provides visibility and networking opportunities with pharmaceutical and healthcare companies.
- Swiss Ophthalmological Society (SOG)minorChief Medical Officer Dr. Kevin Gillman presented on patient, clinical, and operational benefits at the Swiss Ophthalmological Congress, demonstrating the technology to eye care professionals.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
PeriVision competitors and assessment
Company assessmentDirect peers
- Heru: Heru developed FDA-cleared VR-based visual field and vision diagnostics on commodity headsets and was acquired by Topcon Healthcare. Most direct competitor to PeriVision in VR perimetry for glaucoma and general ophthalmic screening.
- Virtual Vision Health: Virtual Vision Health offers FDA-cleared VR visual field testing solutions for optometrists and ophthalmologists. Direct peer targeting the same clinical workflow with a similar hardware-plus-software model.
Broad incumbents
- Carl Zeiss Meditec: Carl Zeiss Meditec is the dominant incumbent in ophthalmic diagnostics, including Humphrey Field Analyzers for perimetry. Broad incumbent with installed base and reimbursement relationships PeriVision must displace.
- Heidelberg Engineering: Heidelberg Engineering manufactures imaging and diagnostic devices for glaucoma management (e.g., HRT, SPECTRALIS). Established incumbent in glaucoma diagnostics competing for the same clinical budget.
- Topcon Healthcare: Topcon Healthcare acquired Heru and markets a broad portfolio of ophthalmic diagnostic instruments. Major incumbent now directly invested in the VR perimetry category through Heru.
- iCare (Revenio Group): iCare manufactures tonometers and glaucoma diagnostic devices used in ophthalmology and optometry. Adjacent incumbent competing for glaucoma diagnostic budget rather than visual field testing per se.
- Natus Medical: Natus produces neurodiagnostic and ophthalmic diagnostic devices used in hospital and clinic settings. Comparable in selling regulated diagnostic instruments into neurology and ophthalmology workflows.
Emerging players
- NovaSight: NovaSight applies eye-tracking-based diagnostics for vision disorders, including pediatric amblyopia and binocular vision assessments. Emerging player with overlapping AI + eye-tracking technology stack.
- MicroMedical Devices: MicroMedical Devices develops portable visual field testing instruments including head-mounted perimeters. Comparable niche player offering alternatives to traditional bowl perimeters.
- RetiSpec: RetiSpec applies AI to ocular imaging for early detection of neurodegenerative and ophthalmic disease. Emerging AI-ophthalmology peer with overlapping eye-based AI clinical workflow.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
PeriVision social profiles
Digital presencePeriVision compliance and trust
Trust signalCompliance2 records
PeriVision financial estimates
Financial estimateRevenue estimate
Valuation estimate
PeriVision leadership team
Management profileNumber of profiles
Profiles5 records
PeriVision funding detail
Funding detailFunding overview
Funding rounds7 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PeriVision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PeriVision
What does PeriVision do?
PeriVision develops and sells VisionOne™, a VR-based visual field diagnostic platform for eye clinics, hospitals, and clinical trial sponsors. The platform combines portable VR headsets, cloud-based test configuration and analysis software, and AI algorithms to perform fast (under 2 minutes) visual field assessments for glaucoma diagnosis and monitoring, including FDA-cleared and CE-cleared capabilities and remote/at-home testing for clinical trials.
Is PeriVision a public or private company?
PeriVision is a private company. It is classified as venture growth investor backed and is currently operating.
When was PeriVision founded?
PeriVision was founded in 2021. It employs 1 to 10 people.
Where is PeriVision based?
PeriVision is headquartered in Epalinges, Switzerland, in the Europe region.
How does PeriVision make money?
Two revenue lines are on record. VisionOne™ VR Platform is the primary driver. The others are cloud Software/SaaS.
Who are PeriVision's main competitors?
Direct peers on record are Heru and Virtual Vision Health. Broad incumbents are Carl Zeiss Meditec, Heidelberg Engineering, Topcon Healthcare, iCare (Revenio Group) and Natus Medical. Emerging players are NovaSight, MicroMedical Devices and RetiSpec.
Does PeriVision have an API?
No public API is recorded for PeriVision.
What industry is PeriVision in?
PeriVision's product category is Ophthalmic Diagnostic Devices. Its primary akta.pro industry code is HLAHAJAC, Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity), with a secondary code of HLAHAJAI, Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty). Its NAICS code is 339115 and its SIC code is 3841.